Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Naltrexone | 3 | 2021 | 70 | 1.410 |
Why?
|
| Hyperinsulinism | 1 | 2020 | 67 | 0.680 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2021 | 137 | 0.670 |
Why?
|
| Stilbenes | 1 | 2017 | 36 | 0.530 |
Why?
|
| Insulin Resistance | 2 | 2020 | 641 | 0.510 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 109 | 0.500 |
Why?
|
| NF-kappa B | 1 | 2017 | 459 | 0.460 |
Why?
|
| Transcription Factor RelA | 2 | 2021 | 54 | 0.350 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 2 | 2022 | 62 | 0.340 |
Why?
|
| Drug Design | 2 | 2022 | 152 | 0.320 |
Why?
|
| Molecular Docking Simulation | 2 | 2020 | 110 | 0.310 |
Why?
|
| Hep G2 Cells | 3 | 2021 | 85 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 1697 | 0.230 |
Why?
|
| Habenula | 1 | 2024 | 41 | 0.220 |
Why?
|
| Light | 1 | 2024 | 176 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 1271 | 0.180 |
Why?
|
| Inflammation | 2 | 2020 | 1446 | 0.180 |
Why?
|
| Lipogenesis | 1 | 2021 | 56 | 0.180 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 39 | 0.180 |
Why?
|
| Insulin-Secreting Cells | 1 | 2022 | 148 | 0.170 |
Why?
|
| Dietary Carbohydrates | 1 | 2021 | 119 | 0.170 |
Why?
|
| Sirtuin 1 | 1 | 2020 | 42 | 0.170 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 177 | 0.160 |
Why?
|
| Protein Binding | 2 | 2020 | 1756 | 0.160 |
Why?
|
| Zinc Oxide | 1 | 2019 | 7 | 0.160 |
Why?
|
| Enzyme Activators | 1 | 2019 | 10 | 0.160 |
Why?
|
| Feeding Behavior | 1 | 2024 | 702 | 0.150 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 188 | 0.150 |
Why?
|
| Cell Nucleus | 1 | 2021 | 676 | 0.150 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2018 | 104 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2019 | 161 | 0.140 |
Why?
|
| Alloxan | 1 | 2017 | 3 | 0.140 |
Why?
|
| Malondialdehyde | 1 | 2017 | 61 | 0.140 |
Why?
|
| Liver | 2 | 2021 | 1748 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2019 | 232 | 0.130 |
Why?
|
| Superoxide Dismutase | 1 | 2017 | 185 | 0.130 |
Why?
|
| Rats, Wistar | 1 | 2017 | 381 | 0.120 |
Why?
|
| Glutathione | 1 | 2017 | 196 | 0.120 |
Why?
|
| Rats | 2 | 2024 | 3727 | 0.120 |
Why?
|
| Animals | 6 | 2024 | 34232 | 0.110 |
Why?
|
| Antioxidants | 1 | 2017 | 369 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 507 | 0.110 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2019 | 398 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2017 | 837 | 0.090 |
Why?
|
| Mice | 3 | 2024 | 17631 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4395 | 0.080 |
Why?
|
| Kidney | 1 | 2017 | 1368 | 0.080 |
Why?
|
| Male | 3 | 2024 | 61525 | 0.060 |
Why?
|
| Humans | 6 | 2024 | 125189 | 0.060 |
Why?
|
| Darkness | 1 | 2024 | 27 | 0.060 |
Why?
|
| Dorsal Raphe Nucleus | 1 | 2024 | 18 | 0.060 |
Why?
|
| Serotonergic Neurons | 1 | 2024 | 24 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 4404 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2024 | 266 | 0.050 |
Why?
|
| Streptozocin | 1 | 2022 | 24 | 0.050 |
Why?
|
| Eating | 1 | 2024 | 368 | 0.050 |
Why?
|
| Glucagon | 1 | 2022 | 184 | 0.050 |
Why?
|
| Nerve Net | 1 | 2024 | 241 | 0.050 |
Why?
|
| Glycation End Products, Advanced | 1 | 2021 | 25 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2021 | 117 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2021 | 267 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2018 | 79 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2018 | 295 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2018 | 171 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 211 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 539 | 0.030 |
Why?
|
| Insulin | 1 | 2022 | 1203 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 4534 | 0.020 |
Why?
|